Vasilaki A - Search Results

1

Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.

Notas G, Kolios G, Mastrodimou N, Kampa M, Vasilaki A, Xidakis C, Castanas E, Thermos K, Kouroumalis E. Notas G, et al. Among authors: vasilaki a. J Hepatol. 2004 May;40(5):792-8. doi: 10.1016/j.jhep.2004.01.016. J Hepatol. 2004. PMID: 15094227

2

Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures.

Vasilaki A, Papadaki T, Notas G, Kolios G, Mastrodimou N, Hoyer D, Tsilimbaris M, Kouroumalis E, Pallikaris I, Thermos K. Vasilaki A, et al. Invest Ophthalmol Vis Sci. 2004 May;45(5):1499-506. doi: 10.1167/iovs.03-0835. Invest Ophthalmol Vis Sci. 2004. PMID: 15111608

3

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.

Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos ON. Kouroumalis E, et al. Among authors: vasilaki a. Gut. 1998 Mar;42(3):442-7. doi: 10.1136/gut.42.3.442. Gut. 1998. PMID: 9577356 Free PMC article. Clinical Trial.

4

Somatostatin receptors (sst2) are coupled to Go and modulate GTPase activity in the rabbit retina.

Vasilaki A, Georgoussi Z, Thermos K. Vasilaki A, et al. J Neurochem. 2003 Feb;84(4):625-32. doi: 10.1046/j.1471-4159.2003.01570.x. J Neurochem. 2003. PMID: 12562507 Free article.

5

The somatostatin receptor (sst1) modulates the release of somatostatin in the nucleus accumbens of the rat.

Vasilaki A, Papasava D, Hoyer D, Thermos K. Vasilaki A, et al. Neuropharmacology. 2004 Sep;47(4):612-8. doi: 10.1016/j.neuropharm.2004.06.008. Neuropharmacology. 2004. PMID: 15380378

6

Antidepressants influence somatostatin levels and receptor pharmacology in brain.

Pallis E, Vasilaki A, Fehlmann D, Kastellakis A, Hoyer D, Spyraki C, Thermos K. Pallis E, et al. Among authors: vasilaki a. Neuropsychopharmacology. 2009 Mar;34(4):952-63. doi: 10.1038/npp.2008.133. Epub 2008 Sep 17. Neuropsychopharmacology. 2009. PMID: 18800063

7

Somatostatin analogues as therapeutics in retinal disease.

Vasilaki A, Thermos K. Vasilaki A, et al. Pharmacol Ther. 2009 Jun;122(3):324-33. doi: 10.1016/j.pharmthera.2009.03.010. Epub 2009 Apr 5. Pharmacol Ther. 2009. PMID: 19351548 Review.

8

Somatostatin mediates nitric oxide production by activating sst(2) receptors in the rat retina.

Vasilaki A, Mouratidou M, Schulz S, Thermos K. Vasilaki A, et al. Neuropharmacology. 2002 Oct;43(5):899-909. doi: 10.1016/s0028-3908(02)00181-8. Neuropharmacology. 2002. PMID: 12384175

9

Somatostatin receptors in wildtype and somatostatin deficient mice and their involvement in nitric oxide physiology in the retina.

Mastrodimou N, Vasilaki A, Papadioti A, Low MJ, Hoyer D, Thermos K. Mastrodimou N, et al. Among authors: vasilaki a. Neuropeptides. 2006 Oct;40(5):365-73. doi: 10.1016/j.npep.2006.07.002. Epub 2006 Sep 28. Neuropeptides. 2006. PMID: 17010429

10

NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina.

Vasilaki A, Gardette R, Epelbaum J, Thermos K. Vasilaki A, et al. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1600-9. Invest Ophthalmol Vis Sci. 2001. PMID: 11381067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters